JIJason Inman

Jason Inman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jason Inman has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Anton Simeonov

    National Institutes of Health

    2 shared publications
  • Carlos A. Tristan

    National Center for Advancing Translational Sciences, Division of Preclinical Innovation, National Institutes of Health, Rockville, MD, United States

    2 shared publications
  • Hyenjong Hong

    National Center for Advancing Translational Sciences (NCATS), Stem Cell Translation Laboratory (SCTL), National Institutes of Health (NIH), Rockville, MD, USA

    2 shared publications
  • Ilyas Singeç

    National Center for Advancing Translational Sciences (NCATS), Stem Cell Translation Laboratory (SCTL), National Institutes of Health (NIH), Rockville, MD 20850, USA

    2 shared publications
  • Seungmi Ryu

    Stem Cell Translation Laboratory (SCTL), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), 9800 Medical Center Drive, Rockville, MD 20850, USA

    2 shared publications
  • Vukasin M. Jovanovic

    National Center for Advancing Translational Sciences (NCATS), Division of Preclinical Innovation Rockville, Rockville, MD 20850, USA

    2 shared publications

Latest Publications

  • Open Access

    Modeling Friedreich’s ataxia with Bergmann glia-enriched human cerebellar organoids

    by Seungmi Ryu, Jason Inman, Hyenjong Hong, Vukasin M. Jovanovic, Qiang Chen, Yeliz Gedik, Yogita Jethmalani, Inae Hur, Majid Harouni, Ty Voss, et al.

    The human cerebellum is implicated in various neurological and psychiatric diseases, but its complex development and cellular diversity have posed challenges for in vitro modeling. Here, we report the generation of human induced pluripotent stem cell (iPSC)-derived cerebellar organoids (hCBOs) that are characterized by induction of rhombomere 1 (R1) cellular identity and followed by derivation of typical neuronal and glial cell types of the cerebellum. In contrast to forebrain organoids with multiple neural rosettes and inside-out neuronal migration, hCBOs develop a germinal zone on the outermost surface of the organoids with outside-in neuronal migration. These hCBOs produce various neuronal cell types resembling granule neurons, Purkinje cells, Golgi neurons, and deep cerebellar nuclei. By using a glial induction strategy, we generate Bergmann glial cells (BGCs) that serve as scaffolds for migratory granule cells and enhance electrophysiological activity of the hCBOs. Furthermore, by generating hCBOs from patients with Friedreich’s ataxia (FRDA), we reveal disease-specific phenotypes that can be reversed by histone deacetylase (HDAC) inhibitors and gene editing by CRISPR-Cas9. Taken together, our advanced hCBO model provides new opportunities to investigate the mechanisms of cerebellar ontogenesis and utilize patient-derived iPSCs for translational research.


  • Open Access

    Stress-free cell aggregation by using the CEPT cocktail enhances embryoid body and organoid fitness

    by Seungmi Ryu, Claire Weber, Pei-Hsuan Chu, Ben Ernest, Vukasin M Jovanovic, Tao Deng, Jaroslav Slamecka, Hyenjong Hong, Yogita Jethmalani, Hannah M Baskir, et al.

    Embryoid bodies (EBs) and self-organizing organoids derived from human pluripotent stem cells (hPSCs) recapitulate tissue development in a dish and hold great promise for disease modeling and drug development. However, current protocols are hampered by cellular stress and apoptosis during cell aggregation, resulting in variability and impaired cell differentiation. Here, we demonstrate that EBs and various organoid models (e.g., brain, gut, kidney) can be optimized by using the small molecule cocktail named CEPT (chroman 1, emricasan, polyamines, trans-ISRIB), a polypharmacological approach that ensures cytoprotection and cell survival. Application of CEPT for just 24 h during cell aggregation has long-lasting consequences affecting morphogenesis, gene expression, cellular differentiation, and organoid function. Various qualification methods confirmed that CEPT treatment enhanced experimental reproducibility and consistently improved EB and organoid fitness as compared to the widely used ROCK inhibitor Y-27632. Collectively, we discovered that stress-free cell aggregation and superior cell survival in the presence of CEPT are critical quality control determinants that establish a robust foundation for bioengineering complex tissue and organ models.


  • Open Access

    LOCUST: a custom sequence locus typer for classifying microbial isolates

    by Lauren M Brinkac, Erin Beck, Jason Inman, Pratap Venepally, Derrick E Fouts, Granger Sutton

    LOCUST is a custom sequence locus typer tool for classifying microbial genomes. It provides a fully automated opportunity to customize the classification of genome-wide nucleotide variant data most relevant to biological research. Source code, demo data, and detailed documentation are freely available at http://sourceforge.net/projects/locustyper. Supplementary data are available at Bioinformatics online.